MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
2) Consolidators: Medical Device Sector
*Consolidators: Surgical Technology
C. R. Bard, Inc. (NYSE: BCR), Inc: #27. Medical Devices, (2013)-CCF/CeMBR
Finance & Acquisitions: Bard
Lutonix
Attachments
Moxy | Overview
Parents
*Architects: Surgical Technology _ Cardiovascular, Cardiac & Cardiology Companies
*Industry: Minnesota
Companies: Acquired_(M&A)
Finance & Acquisitions: Bard
Children
Belarus
C R Bard Acquires Lutonix Inc for Up to $325 million (2011)
Drug coated balloon angioplasty technology for the treatment and prevention of coronary and peripheral artery stenosis caused by atherosclerosis
Founded 2007
Lutonix Inc. Announces $20 Million Series B Financing (2008)
Lutonix is a medical device company developing drug-coated balloon catheters for the treatment of vascular disease.
Maple Grove, Minnesota
Round led by Versant Ventures, Delphi Ventures, U.S. Venture Partners, and RiverVest Venture Partners
Surgical Devices